BMS, Novartis to evaluate combo cancer drug

Bristol-Myers Squibb (BMS) collaborates with Novartis to evaluate its Opdivo (nivolumab) in combination with targeted therapies from Novartis to treat Non-Small Cell Lung Cancer (NSCLC)

id-100175951

Opdivo is part of a new class of cancer treatments known as immunotherapies

Bristol-Myers Squibb (BMS) has announced the establishment of a clinical trial collaboration with Novartis. The collaboration aims to evaluate the safety, tolerability and preliminary efficacy of its investigational PD-1 immune checkpoint inhibitor Opdivo (nivolumab) with three molecularly targeted oncology therapies (Zykadia (ceritinib), INC280 and EGF816) from Novartis. Novartis will conduct two Phase 1/2 studies focused on non-small cell lung cancer (NSCLC).

"Bristol-Myers Squibb is committed to advancing the science, research and development of immunotherapy as an innovative approach to treating cancer in multiple tumor types," said Mr Michael Giordano, senior vice president, Oncology Development, BMS.

"Combining Opdivo with select targeted agents from Novartis complements our broad global development strategy of immuno-oncology combinations across the spectrum of lung cancer settings, and supports our goal of improving outcomes for patients", he added.

Opdivo is part of a new class of cancer treatments known as immunotherapies designed to harness the body's own immune system in fighting cancer, and targets distinct regulatory components of the immune system.

Zykadia, INC280 and EGF816 have each demonstrated evidence of targeting specific molecules responsible for tumor growth in NSCLC patient populations. The studies will explore the potential of enhanced anti-tumor response using a combined immunotherapy and targeted molecular approach.

 

1 Comment Comment 1 - 1 of 1
comment

MARY ROBERT 22 June 2015 at 09:43 AM

Good day My Name is Mary Robert i am her to share a great testimony of my life i was cure from HIV and cure my friend the disease called ALS by a Doctor Name DR CUBA i have been surfering HIV/ALS from 5 year i saw doctor Email on the internet so i contact him and i explain to him i follow up the instruction behold 6 days later after taking the cure i went for a HIV text to my surprise it was Negative my family doctor was surprise my husband who abandon me was surprise my brother if you no that you are positive please i will advise you to contact him now and see for your self his Email is drcubatemple@gmail.com why is website is......[ www.dr-cubatemple.webs.com] and also you can contact him on whatsapp +2347038965900

Reply

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X